Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis_hq_day

Colombian government forces through near half-price cut of Novartis drug

December 21, 2016
Medical Communications, Sales and Marketing Colombia, Novartis

The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …

News
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

New research reverses HIV-related immune suppression

December 21, 2016
Research and Development HIV, UNC School of Medicine

The UNC School of Medicine has released new research which appears to offer a new approach to HIV treatment which …

News
fdaoutsideweb

FDA new drug approvals sink to six year low

December 21, 2016
Medical Communications, Research and Development FDA, NDA, new drug approvals

The FDA has released figures to show that drug approvals have fallen from last year’s high of 45 new drugs …

News
allergan

Allergan shells out $2.9bn for regenerative medicine unit LifeCell

December 21, 2016
Research and Development, Sales and Marketing Allergan, LifeCell, acquisition

Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …

News

Novartis seals two deals to bolster drug pipeline

December 21, 2016
Research and Development Conatus, Encore Vision, Novartis

Novartis has consolidated its ophthalmology position by acquiring Encore Vision, a Fort Worth-based US company. The company is focused on …

News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

Appointment
640px-prostatic_adenocarcinoma_with_perineural_invasion

Treatment using light and deep-sea bacteria kills cancer cells

December 20, 2016
Medical Communications, Research and Development Vascular-targeted photodynamic therapy

A technique called vascular-targeted photodynamic therapy (VTP) has been developed that sent 49% of patients suffering from prostate cancer into …

News

Japan announces measure to crack down on drug pricing

December 20, 2016
Manufacturing and Production, Medical Communications Japan, Shinzo Abe, opdivo

Japan has committed to annual drug price reviews whilst also expanding the scope by which the prices are deemed to …

News

J&J’s largest India site to finally operate by 2018

December 20, 2016
Manufacturing and Production India, Johnson & Johnson

Johnson & Johnson has reportedly announced that its manufacturing plant in Telangana, India, its largest site in the country, is …

News

AstraZeneca opens £120 million UK manufacturing facility

December 20, 2016
Manufacturing and Production AstraZeneca, Macclesfield

AstraZeneca has officially opened a new manufacturing facility for cancer medicines based in Macclesfield, UK. It becomes the second largest …

News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 19, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

News
ionis

Ionis achieves successful Phase 3 trial to treat rare diseases

December 19, 2016
Manufacturing and Production, Research and Development Akcea, Ionis, rare disease

Ionis Pharmaceutial announced that the results of a Phase 3 trial into its treatment for hypertriglyceridemia met its primary endpoint. …

News
astrazeneca_building_white

AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal

December 19, 2016
Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS

AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …

News
robert_ross_md

Robert Ross joins Surface Oncology as chief medical officer

December 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio

Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …

Appointment
nice_reception_small_size

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …

Feature
fda2outsideweb

FDA orders new label warnings over anaesthetics risk in children

December 19, 2016
Research and Development, Sales and Marketing FDA, anaesthetics

The FDA has announced a new Drug Safety Communication for label warnings on general anaesthetic and sedation products because of …

News
novartis_window

Novartis acquires Ziarco adding to dermatology pipeline

December 19, 2016
Sales and Marketing Novartis, Ziarco, eczema, oral

Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …

News
smoke-1001664_1280

FDA removes black box warning on Pfizer’s anti-smoking medication

December 19, 2016
Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking

The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …

News
1280px-epi-pen_1

Mylan launches $300 generic EpiPen to calm pricing controversy

December 16, 2016
Sales and Marketing Mylan, epipen

Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …

News
bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …

Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026